Literature DB >> 18842786

Human fetal albumin synthesis rates during different periods of gestation.

Chris H P van den Akker1, Henk Schierbeek, Trinet Rietveld, Andras Vermes, Johannes J Duvekot, Eric A P Steegers, Johannes B van Goudoever.   

Abstract

BACKGROUND: Despite nutritional intervention, albumin concentrations are often low in critically ill premature neonates.
OBJECTIVE: Our aim was to quantify albumin synthesis rates during early life under physiologic circumstances. Human fetuses thereby reflect the developmentally related optimal condition.
DESIGN: Pregnant women undergoing elective cesarean delivery received 3 different labeled amino acid infusions starting at different times before surgery. With the use of mass spectrometry techniques, this novel model enabled us to quantify fetal albumin synthesis from a single blood sample taken from the umbilical cord after cesarean delivery. The fractional synthesis rate reflects the fraction of the albumin pool that is daily renewed. The absolute synthesis rate is the absolute amount of albumin that is daily synthesized. Results are expressed as medians (25th-75th percentile).
RESULTS: We studied 8 fetuses at 29.9 (28.4-35.4) weeks of gestation and 8 fetuses around term. Fractional synthesis rates in premature fetuses [17.5 (12.1-24.4) %/d] were higher (P = 0.02) than in mature fetuses [10.4 (9.1-13.7) %/d]. Absolute synthesis rates were also higher (P = 0.02) in premature than in mature fetuses: 280 (227-365) versus 205 (184-238) mg . kg(-1) . d(-1).
CONCLUSIONS: On a weight basis, albumin synthesis rates in premature fetuses were higher than in fetuses at term and were higher than the rates previously found in neonates after preterm birth. Considering that the premature fetal liver can synthesize albumin at a high rate, the observed hypoalbuminemia in premature infants therefore seems to suggest that current (nutritional) therapies fail to meet requirements necessary to sustain optimum albumin synthesis rates.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18842786     DOI: 10.1093/ajcn/88.4.997

Source DB:  PubMed          Journal:  Am J Clin Nutr        ISSN: 0002-9165            Impact factor:   7.045


  9 in total

1.  Inverse association between maternal 25OHD level and cord GLP-1/GIP concentrations.

Authors:  Shimpei Niwa; Hidetoshi Mezawa; Naoaki Kobayashi; Hiroyuki Ida; Mitsuyoshi Urashima
Journal:  Pediatr Res       Date:  2015-12-09       Impact factor: 3.756

2.  Prediction of Fetal Darunavir Exposure by Integrating Human Ex-Vivo Placental Transfer and Physiologically Based Pharmacokinetic Modeling.

Authors:  Stein Schalkwijk; Aaron O Buaben; Jolien J M Freriksen; Angela P Colbers; David M Burger; Rick Greupink; Frans G M Russel
Journal:  Clin Pharmacokinet       Date:  2018-06       Impact factor: 6.447

3.  Prenatal Exposure to Perfluoroalkyl Substances and Cardiometabolic Risk in Children from the Spanish INMA Birth Cohort Study.

Authors:  Cyntia B Manzano-Salgado; Maribel Casas; Maria-Jose Lopez-Espinosa; Ferran Ballester; Carmen Iñiguez; David Martinez; Dora Romaguera; Silvia Fernández-Barrés; Loreto Santa-Marina; Mikel Basterretxea; Thomas Schettgen; Damaskini Valvi; Jesus Vioque; Jordi Sunyer; Martine Vrijheid
Journal:  Environ Health Perspect       Date:  2017-09-20       Impact factor: 9.031

4.  The effect of dapagliflozin on apolipoprotein B and glucose fluxes in patients with type 2 diabetes and well-controlled plasma LDL cholesterol.

Authors:  Kristien E C Bouter; Erik J M van Bommel; Hans Jansen; Dewi van Harskamp; Henk Schierbeek; Mariëtte T Ackermans; Mireille J Serlie; Alinda W M Schimmel; Max Nieuwdorp; Geesje M Dallinga-Thie; Daniël H van Raalte
Journal:  Diabetes Obes Metab       Date:  2020-02-27       Impact factor: 6.577

5.  To study the association between various levels of cord serum albumin (CSA) and significant neonatal hyperbilirubinemia requiring interventions like phototherapy or exchange transfusion.

Authors:  Apeksha Pathak; R Siddalingesha; Kamal N Prasad; Nibha Kamal; Archana Sinha; Ananya Ghosh; Bhuwan K Singh; Pankaj Kumar; R Surekha
Journal:  J Family Med Prim Care       Date:  2022-06-30

6.  Robust reference intervals for liver function test (LFT) analytes in newborns and infants.

Authors:  Mulugeta Melkie; Mahilet Yigeremu; Paulos Nigussie; Shawel Asrat; Tatek Gebreegziabher; Tilahun Teka; Samuel Kinde
Journal:  BMC Res Notes       Date:  2012-09-07

7.  Human Hepatocyte-Derived Induced Pluripotent Stem Cells: MYC Expression, Similarities to Human Germ Cell Tumors, and Safety Issues.

Authors:  Carmen Unzu; Marc Friedli; Alexis Bosman; Marisa E Jaconi; Barbara E Wildhaber; Anne-Laure Rougemont
Journal:  Stem Cells Int       Date:  2016-01-06       Impact factor: 5.443

8.  Association of cord serum albumin with neonatal hyperbilirubinemia among term appropriate-for-gestational-age neonates.

Authors:  Asit Kumar Mishra; C Sanyasi Naidu
Journal:  Int J Pediatr Adolesc Med       Date:  2018-12-13

9.  ANGPTL3 Inhibition With Evinacumab Results in Faster Clearance of IDL and LDL apoB in Patients With Homozygous Familial Hypercholesterolemia-Brief Report.

Authors:  Laurens F Reeskamp; John S Millar; Liya Wu; Hans Jansen; Dewi van Harskamp; Henk Schierbeek; Daniel A Gipe; Daniel J Rader; Geesje M Dallinga-Thie; G Kees Hovingh; Marina Cuchel
Journal:  Arterioscler Thromb Vasc Biol       Date:  2021-03-11       Impact factor: 8.311

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.